Evidence map›Paper›PMID 31142527›Full record

ArticleBMJ open2019

General practitioner use of D-dimer in suspected venous thromboembolism: historical cohort study in one geographical region in the Netherlands.

Angel M R Schols, Eline Meijs, Geert-Jan Dinant, Henri E J H Stoffers, Mariëlle M E Krekels, Jochen W L Cals

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Angel M R ScholsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.
Eline MeijsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.
Geert-Jan DinantDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.
Henri E J H StoffersDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.
Mariëlle M E KrekelsZuyderland Medical Centre, Sittard, the Netherlands.
Jochen W L CalsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands.
Maastricht University · NLZuyderland Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate how many general practitioner (GP)-referred venous thromboembolic events (VTEs) are diagnosed during 1 year in one geographical region and to investigate the (urgent) referral pathway of VTE diagnoses, including the role of laboratory D-dimer testing.

designHistorical cohort study.

settingGP patients of 47 general practices in a demarcated geographical region of 161 503 inhabitants in the Netherlands.

participantsWe analysed all 895 primary care patients in whom either the GP determined a D-dimer value or who had a diagnostic work-up for suspected VTE in a non-academic hospital during 2015. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcomes of this study were the total number of VTEs per year and the diagnostic pathways-including the role of GP determined D-dimer testing-of patients urgently referred to secondary care for suspected VTE. Additionally, we explored the use of an age-adjusted D-dimer cut-off.

resultsThe annual VTE incidence was 0.9 per 1000 inhabitants. GPs annually ordered 5.1 D-dimer tests per 1000 inhabitants. Of 470 urgently GP-referred patients, 31.3% had a VTE. Of those urgently referred based on clinical assessment only (without D-dimer testing), 73.8% (96/130) had a VTE; based on clinical assessment and laboratory D-dimer testing yielded 15.0% (51/340) VTE. Applying age-adjusted D-dimer cut-offs to all patients aged 50 years or older resulted in a reduction of positive D-dimer results from 97.9% to 79.4%, without missing any VTE.

conclusionsAlthough D-dimer testing contributes to the diagnostic work-up of VTE, GPs have a high detection rate for VTE in patients who they urgently refer to secondary care based on clinical assessment only.

Indexed as

General PractitionersAdolescentAdultAgedAged, 80 and overAntifibrinolytic AgentsCohort StudiesFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedNetherlandsPractice Patterns, Physicians'Primary Health CareTreatment OutcomeAntifibrinolytic AgentsFibrin Fibrinogen Degradation Productsfibrin fragment Depidemiologygeneral medicine (see internal medicine)primary carethromboembolism

Identifiers

PMID31142527
PMCPMC6549605
OpenAlexW2947491067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.